NeuralinkPRIVATE · FOUNDED 2016Each bar is the last disclosed mark — $1B for Alloy Therapeutics (post-money, Apr 2026) and $9B for Neuralink (post-money, Jun 2025).

NeuralinkPRIVATEHealth · US · 2016
The $9B tells you…Both marks are post-money, so 9.00× compares like with like. Both are private: there is no public quote and no Canborsa market on either name.
Alloy Therapeutics' sector is Biotech; Neuralink's sector is Neurotechnology / medical devices.
Alloy Therapeutics is valued at $1B, and Neuralink at $9B.
Alloy Therapeutics was founded in 2011, and Neuralink was founded in 2016.
Alloy Therapeutics has about 50 employees, and Neuralink has about 300.
Alloy Therapeutics is private, and Neuralink is private.